A patient diagnosed with glioblastoma multiforme should be treated by a multidisciplinary team that includes neurosurgeons, neurologists, neuro-oncologists, neuroradiologists, neuropathologists, radiation oncologists, physical therapists, social workers, and other specialists with advanced training and extensive experience in brain tumors. The Weill Cornell Neurological Surgery offers the services of some of the top surgeons in the field as well as access to a full range of specialists in all the disciplines an adult patient needs. (See also: Doctors Who Treat Brain Tumors in Children.)
Philip E. Stieg, Ph.D., M.D., the chair and neurosurgeon-in-chief of the Weill Cornell Medicine Neurological Surgery, leads the cerebrovascular team. Dr. Stieg is one of the top neurosurgeons in the nation, having been named one of America’s Top Doctors by Castle Connolly each year since that designation was created nearly two decades ago. Dr. Stieg has developed an international reputation in the area of cerebrovascular disorders and surgery; his work has been broadly published, and he has contributed to groups such as the Joint Sections of Cerebrovascular Surgery of the American Association of Neurological Surgeons and Congress of Neurological Surgeons (AANS/CNS). He is the past President of the Society of University Neurosurgeons and has received multiple awards and honors for his work. (Read more about Dr. Stieg.)
Theodore H. Schwartz, M.D., specializes in the surgical treatment of brain tumors, pituitary tumors, and epilepsy surgery using the latest techniques in computer-guided surgical navigation, minimally invasive endoscopy, and microsurgery. Dr. Schwartz has been named to the lists of New York's Super Doctors, Best Doctors in New York magazine, America's Top Surgeons, America's Best Doctors, and America's Best Doctors for Cancer. (Read more about Dr. Schwartz.)
Susan Pannullo, M.D. is board-certified in both Neurology and Neurological Surgery and specializes in stereotactic radiosurgery. Dr. Pannullo is one of the few neurosurgeons in the United States with access to Brainlab iX, Gamma Knife, and CyberKnife, all of which allow non-invasive treatment of brain tumors and other conditions of the brain and spine. (Read more about Dr. Pannullo.)
Rohan Ramakrishna, M.D., is an award-winning neurosurgeon who specializes in the treatment of brain tumors and other central nervous system tumors. Dr. Ramakrishna treats patients with gliomas, metastatic disease, skull base lesions, and pituitary disorders. He employs advanced awake mapping, imaging techniques, and microsurgery to ensure maximal tumor removal and achieve the safest possible surgical outcomes. (Read more about Dr. Ramakrishna.)
Ning Lin, M.D. brings a unique combination of neurosurgical and endovascular experience in treating a wide range of vascular diseases of the brain and spine. He has published multiple articles in peer-reviewed medical journals and presented in national neurosurgery conferences on the topic of glioblastoma multiforme. Dr. Lin sees patients and performs surgery at NewYork-Presbyterian/Weill Cornell Medical Center and NewYork-Presbyterian/Queens. (Read more about Dr. Lin.)
At Weill Cornell Medicine, our neurosurgeons are highly skilled in the most advanced minimally invasive procedures for treating brain tumors. Our relationship with NewYork/Presbyterian Hospital allows our surgeons access to the very best facilities and specialists, as well as the most leading-edge research laboratories, to ensure that you gets the very best treatment available. You can request an appointment using our online form.
At NewYork-Presbyterian Queens:
John Park, MD, PhD, is chief of neurosurgery at NewYork-Presbyterian Queens. A board-certified and award-winning neurosurgeon, Dr. Park has particular expertise in the treatment of brain and spinal tumors and degenerative disorders of the cervical and lumbar spine. While at the National Institutes of Health Clinical Center in Bethesda, Maryland, Dr. Park developed a national reputation for the surgical treatment of low-grade gliomas and recurrent malignant gliomas and served as the principal neurosurgeon for patients enrolled in NCI clinical trials for malignant gliomas. (Read more about Dr. Park.)